Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 10/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 8/20 | 1.00 |
| ▸ | MMP3 | P08254 | 3/20 | 1.00 |
| ▸ | MMP13 | P45452 | 3/20 | 1.00 |
| ▸ | GFER | P55789 | 1/20 | 0.79 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.76 |
| ▸ | MEN1 | O00255 | 2/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.70 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19736228 | 1.00 | AKR1B1 (1.00) | AKR1B1PTPN1MMP3MMP13GFER | |
| SCHEMBL17319262 | 1.00 | AKR1B1 (1.00) | AKR1B1PTPN1MMP3MMP13GFER | |
| SCHEMBL6886682 | 0.91 | AKR1B1 (0.83) | AKR1B1PTPN1MMP3MMP13GFER | |
| SCHEMBL25997484 | 0.91 | AKR1B1 (0.83) | AKR1B1PTPN1MMP3MMP13GFER | |
| SCHEMBL19736097 | 0.91 | AKR1B1 (0.83) | AKR1B1PTPN1MMP3MMP13GFER | |
| SCHEMBL29408634 | 0.91 | AKR1B1 (0.83) | AKR1B1PTPN1MMP3MMP13GFER | |
| SCHEMBL6886677 | 0.91 | AKR1B1 (0.83) | AKR1B1PTPN1MMP3MMP13GFER | |
| SCHEMBL6879197 | 0.89 | AKR1B1 (0.81) | AKR1B1PTPN1MMP3MMP13ADAMTS5 | |
| SCHEMBL6879199 | 0.89 | AKR1B1 (0.81) | AKR1B1PTPN1MMP3MMP13ADAMTS5 | |
| SCHEMBL20534415 | 0.89 | AKR1B1 (1.00) | AKR1B1PTPN1MMP3MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2210940-B2 | METHOD FOR HIGH-LEVEL SECRETION AND PRODUCTION OF PROTEIN | DAIICHI SANKYO CO LTD (JP) | 2018-07-18 | — | — | EP | claimed |
| EP-2022855-B1 | HIGH SECRETION PRODUCTION METHOD OF PROTEIN | DAIICHI SANKYO CO LTD (JP) | 2015-08-19 | — | — | EP | claimed |
| EP-2210940-B1 | METHOD FOR HIGH-LEVEL SECRETION AND PRODUCTION OF PROTEIN | DAIICHI SANKYO CO LTD (JP) | 2015-03-11 | — | — | EP | claimed |
| US-8409825-B2 | Method for high-level secretory production of protein | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2013-04-02 | — | — | US | claimed |
| US-8232377-B2 | Method for high-level secretory production of protein | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2012-07-31 | — | — | US | claimed |
| US-20110014651-A1 | METHOD FOR HIGH-LEVEL SECRETORY PRODUCTION OF PROTEIN | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2011-01-20 | — | — | US | claimed |
| EP-2210940-A1 | METHOD FOR HIGH-LEVEL SECRETION AND PRODUCTION OF PROTEIN | Daiichi Sankyo Company, Limited (JP) | 2010-07-28 | — | — | EP | claimed |
| US-20090191587-A1 | METHOD FOR HIGH-LEVEL SECRETORY PRODUCTION OF PROTEIN | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGKY | 2009-07-30 | — | — | US | claimed |
| EP-2022855-A1 | HIGH SECRETION PRODUCTION METHOD OF PROTEIN | Kirin Pharma Kabushiki Kaisha (JP) | 2009-02-11 | — | — | EP | claimed |
| US-20220378751-A1 | INHIBITING DIHYDROFOLATE REDUCTASE IN A MICROORGANISM | VERSITECH LIMITED (HK) | 2022-12-01 | — | — | US | disclosed |
| CN-109414432-B | Antimicrobial compounds and methods of use thereof | 港大科桥有限公司 | 2022-03-08 | — | — | CN | disclosed |
| EP-3196304-B1 | METHOD FOR IMPROVED HIGH-LEVEL SECRETORY PRODUCTION OF PROTEINS | DAIICHI SANKYO CO LTD (JP) | 2021-10-06 | — | — | EP | disclosed |
| EP-2210940-B2 | METHOD FOR HIGH-LEVEL SECRETION AND PRODUCTION OF PROTEIN | DAIICHI SANKYO CO LTD (JP) | 2018-07-18 | — | — | EP | disclosed |
| US-20170211063-A1 | METHOD FOR IMPROVED HIGH-LEVEL SECRETORY PRODUCTION OF PROTEIN | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2017-07-27 | — | — | US | disclosed |
| US-8409825-B2 | Method for high-level secretory production of protein | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2013-04-02 | — | — | US | disclosed |
| US-8232377-B2 | Method for high-level secretory production of protein | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2012-07-31 | — | — | US | disclosed |
| US-20110014651-A1 | METHOD FOR HIGH-LEVEL SECRETORY PRODUCTION OF PROTEIN | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2011-01-20 | — | — | US | disclosed |
| EP-2210940-A1 | METHOD FOR HIGH-LEVEL SECRETION AND PRODUCTION OF PROTEIN | Daiichi Sankyo Company, Limited (JP) | 2010-07-28 | — | — | EP | disclosed |
| US-20090191587-A1 | METHOD FOR HIGH-LEVEL SECRETORY PRODUCTION OF PROTEIN | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGKY | 2009-07-30 | — | — | US | disclosed |
| EP-2022855-A1 | HIGH SECRETION PRODUCTION METHOD OF PROTEIN | Kirin Pharma Kabushiki Kaisha (JP) | 2009-02-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220378751-A1 | INHIBITING DIHYDROFOLATE REDUCTASE IN A MICROORGANISM | DHFR, BLVRB, QDPR | AKR1B1 92/4885PTPN1 1854/4885MMP3 1947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.